NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.

导出 LinkOut

翻译打印收藏纠错

作者： Christoph,Schulz ^[1] ; Frank,Kullmann ^[2] ; Volker,Kunzmann ^[3] ; Martin,Fuchs ^[4] ; Michael,Geissler ^[5] ; Ursula,Vehling-Kaiser ^[6] ; Heribert,Stauder ^[7] ; Axel,Wein ^[8] ; Salah-Eddin,Al-Batran ^[9] ; Thomas,Kubin ^[10] ; Claus,Schäfer ^[11] ; Sebastian,Stintzing ^[1] ; Clemens,Giessen ^[1] ; Dominik Paul,Modest ^[1] ; Karsten,Ridwelski ^[12] ; Volker,Heinemann ^[1]

作者单位： Department of Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center, University of Munich, Munich, Germany. ^[1] Department of Internal Medicine I, Hospital Nordoberpfalz, Weiden, Germany. ^[2] Department of Internal Medicine II, Department of Medical Oncology, University of Würzburg, Würzburg, Germany. ^[3] Department of Gastroenterology, Hepatology and GI-Oncology, Hospital Bogenhausen, München, Germany. ^[4] Department of Medical Oncology, Gastroenterology and Internal Medicine, Hospital Esslingen, Esslingen, Germany. ^[5] Center of Oncology, Landshut, Germany. ^[6] Department of Medical Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany. ^[7] Department of Internal Medicine I, University of Erlangen, Germany. ^[8] University Cancer Center, Krankenhaus Nordwest, Frankfurt, Germany. ^[9] Department of Hematology and Medical Oncology, Klinikum Traunstein, Traunstein, Germany. ^[10] Department of Internal Medicine II, Hospital Neumarkt i.d.OPf, Neumarkt i.d.OPf, Germany. ^[11] Department of Surgery, Hospital Magdeburg, Magdeburg, Germany. ^[12]

关键词 R0 resection rate adenocarcinoma of the gastroesophageal junction gastric cancer neoadjuvant chemotherapy pCR